Stridebio, Inc

stridebio, inc is a gene therapy company focused on creating and developing novel adeno-associated viral (aav) vector technologies and therapeutics for rare diseases. our structure inspired design approach holds the potential to generate unique aav capsids capable of overcoming the challenges of pre-existing neutralizing antibodies and improving gene transfer efficiency in patients. this powerful new approach has broad application, enabling gene addition, gene silencing and gene editing modalities for a wide range of diseases, including rare genetic diseases. stridebio is headquartered in durham, nc.